*Please note*
Since this session was recorded on December 10, 2020, an article was published in the New England Journal Of Medicine detailing the Pfizer-BioNTech SE vaccine safety and efficacy clinical trial (www.nejm.org/d....
This publication details the types of patients which were included and excluded from the trial (in the supplementary documents section and also on clinicaltrials.... Unfortunately, the study specifically excluded people who are immunocompromised, those with autoimmune conditions, and patients on immunosuppressive therapy. This means that the safety and efficacy of the vaccine has not been tested in this population. However, the fact that these patients were excluded does not mean that patients who are immunocompromised or taking immunosuppressive medications cannot or should not take the vaccine. In fact, it seems that the Centers for Disease Control (CDC) will likely prioritize vaccination in this population. However, if you are on immunosuppressive medication, it is possible that the vaccine may not be as effective (just like with other vaccines).
I urge you to look for forthcoming guidance from the CDC (www.cdc.gov/co...) and to also talk to your doctor. In the meantime, please continue to protect your selves by wearing masks and socially distancing yourself.
Divya C. Patel
Негізгі бет COVID-19 Q&A with Dr. Divya Patel
Пікірлер: 7